Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy
- 1 July 2003
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Gastroenterology
- Vol. 37 (1), 42-47
- https://doi.org/10.1097/00004836-200307000-00012
Abstract
Although the etiology of idiopathic ulcerative colitis (UC) remains poorly understood, the intestinal flora is suspected to play an important role. Specific, consistent abnormalities in flora composition peculiar to UC have not yet been described, however Clostridium difficile colitis has been cured by the infusion of human fecal flora into the colon. This approach may also be applicable to the treatment of UC on the basis of restoration of flora imbalances. To observe the clinical, colonoscopic and histologic effects of human probiotic infusions (HPI) in 6 selected patients with UC. Six patients (3 men and 3 women aged 25–53 years) with UC for less than 5 years were treated with HPI. All patients had suffered severe, recurrent symptoms and UC had been confirmed on colonoscopy and histology. Fecal flora donors were healthy adults who were extensively screened for parasites and bacterial pathogens. Patients were prepared with antibiotics and oral polyethylene glycol lavage. Fecal suspensions were administered as retention enemas within 10 minutes of preparation and the process repeated daily for 5 days. By 1 week post-HPI some symptoms of UC had improved. Complete reversal of symptoms was achieved in all patients by 4 months post-HPI, by which time all other UC medications had been ceased. At 1 to 13 years post-HPI and without any UC medication, there was no clinical, colonoscopic, or histologic evidence of UC in any patient. Colonic infusion of donor human intestinal flora can reverse UC in selected patients. These anecdotal results support the concept of abnormal bowel flora or even a specific, albeit unidentified, bacterial pathogen causing UC.Keywords
This publication has 28 references indexed in Scilit:
- Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?Gastroenterology, 1999
- The Effect of Faecal Enema on Five Microflora-Associated Characteristics in Patients with Antibiotic-Associated DiarrhoeaScandinavian Journal of Gastroenterology, 1999
- Inflammatory bowel disease: Etiology and pathogenesisGastroenterology, 1998
- Faecal Short-Chain Fatty Acids in Patients with Antibiotic-Associated Diarrhoea, before and after Faecal Enema TreatmentScandinavian Journal of Gastroenterology, 1998
- The influence of normal microbial flora on the development of chronic mucosal inflammationResearch in Immunology, 1997
- Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1995
- Permeability in Crohn's disease: Altered barrier functions in healthy relatives?Gastroenterology, 1993
- BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTSThe Lancet, 1989
- TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORAThe Lancet, 1989
- RELAPSING CLOSTRIDIUM DIFFICILE ENTEROCOLITIS CURED BY RECTAL INFUSION OF HOMOLOGOUS FAECESThe Lancet, 1983